According to the Financial APP, Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company obtained information about the pharmaceutical GMP compliance inspection results announcement (Zhe2024 No. 0205) from the Zhejiang Provincial Drug Administration website. This time, the company passed the pharmaceutical GMP compliance inspection, indicating that the company's relevant production lines and drugs meet GMP requirements, which is conducive to further enriching the product variety, maintaining stable production capacity, and meeting market demand.